Jose M Alvarez-Dobano
Overview
Explore the profile of Jose M Alvarez-Dobano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez-Dobano J, Rodriguez-Garcia C, Atienza G, Toubes M, Rodriguez-Nunez N, Zamarron C, et al.
Respir Med
. 2024 Jan;
222:107514.
PMID: 38171405
Introduction: The quality of e-Consultations in the COPD is unknown. The objectives of this study were (i) to evaluate the quality of referrals; (ii) to define the characteristics of patients...
2.
Pou C, Ferreiro L, Suarez-Antelo J, Golpe A, Alvarez-Dobano J, Toubes M, et al.
Ann Thorac Med
. 2023 Jun;
18(2):53-60.
PMID: 37323369
The characteristics of patients with pleural amyloidosis (PA) are poorly known. A systematic review was performed of studies reporting clinical findings, pleural fluid (PF) characteristics, and the most effective treatment...
3.
Riveiro V, Casal A, Alvarez-Dobano J, Lourido T, Suarez-Artime P, Rodriguez-Garcia C, et al.
Clin Respir J
. 2022 Aug;
16(11):768-773.
PMID: 36017771
Introduction: Inhaled antibiotics reduce the frequency of exacerbations. The objective was to assess the efficacy of inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis (NCFB) and concomitant chronic bronchial infection...
4.
Rodriguez-Nunez N, Ruano-Ravina A, Lama A, Ferreiro L, Ricoy J, Alvarez-Dobano J, et al.
J Thorac Dis
. 2021 Oct;
13(9):5373-5382.
PMID: 34659804
Background: An integrated care pathway (ICP) is intended to improve the management of prevalent resource-consuming, life-threatening diseases. The purpose of this study was to determine whether the quality of patient...
5.
Rodriguez-Nunez N, Ruano-Ravina A, Lama A, Ferreiro L, Ricoy J, Alvarez-Dobano J, et al.
J Thorac Dis
. 2020 Nov;
12(10):5411-5419.
PMID: 33209374
Background: The nature of pulmonary embolism (PE) without identifiable risk factor (IRF) remains unclear. The objective of this study is to investigate the potential relationship between cardiovascular risk factors (CVRFs)...
6.
Abelleira R, Zamarron C, Ruano A, Lourido T, Rodriguez-Nunez N, Gonzalez-Barcala F, et al.
Med Clin (Barc)
. 2020 Aug;
157(3):106-113.
PMID: 32829922
Introduction: Diabetes mellitus and sleep apnoea-hypopnoea syndrome appear to be related, but it is not well defined whether there is an increased risk of peripheral neuropathy in patients with both...
7.
Toubes M, Lama A, Ferreiro L, Golpe A, Alvarez-Dobano J, Gonzalez-Barcala F, et al.
J Thorac Dis
. 2017 Jun;
9(5):1209-1218.
PMID: 28616270
Background: The characteristics of patients with urinothorax (UT) are poorly defined. Methods: A systematic review was performed searching for studies reporting clinical findings, pleural fluid (PF) characteristics, and the most...
8.
Rodriguez-Nunez N, Ruano-Ravina A, Abelleira R, Ferreiro L, Lama A, Gonzalez-Barcala F, et al.
Arch Bronconeumol
. 2017 Feb;
53(8):432-436.
PMID: 28238515
Introduction: The aim of this study was to identify factors influencing hospital stay due to pulmonary embolism. Methods: We performed a retrospective cohort study of patients hospitalized between 2010 and...
9.
Ferreiro L, Gude F, Toubes M, Lama A, Suarez-Antelo J, San-Jose E, et al.
J Thorac Dis
. 2017 Feb;
9(1):106-116.
PMID: 28203412
Background: There are no firm recommendations when cytology should be performed in pleural transudates, since some malignant pleural effusions (MPEs) behave biochemically as transudates. The objective was to assess when...
10.
Lama A, Ferreiro L, Toubes M, Golpe A, Gude F, Alvarez-Dobano J, et al.
J Thorac Dis
. 2016 Sep;
8(8):2093-101.
PMID: 27621864
Background: Pseudochylothorax (PCT) (cholesterol pleurisy or chyliform effusion) is a cholesterol-rich pleural effusion (PE) that is commonly associated with chronic inflammatory disorders. Nevertheless, the characteristics of patients with PCT are...